Cellebrite DI Ltd. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $24.95M 20-F · filed 2026-03-03 | |
| 2024-12-31 | $20.48M 20-F · filed 2026-03-03 | |
| 2023-12-31 | $21.73M 20-F · filed 2024-03-21 | |
| 2022-12-31 | $13.73M 20-F · filed 2024-03-21 | |
| 2021-12-31 | $2.31M 20-F · filed 2024-03-21 | |
| 2020-12-31 | $1.49M 20-F · filed 2023-04-27 |